(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMYLOBAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AMYLOBAN

ST13

US500000077976786

Class

5

Filing

77976786

Registration

3636695

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

01/07/2020

Trademark type

Word

Nice classes

5

Filing date

06/19/2007

Registration date

06/09/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2020

Last transaction

01/07/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/24/2008

First use in commerce

06/24/2008

Drawing code

4

Owner type

03

Owner location

EAST RUTHERFORD, NJ

Examiner

YARD, JOHN

Law office

M60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MUSHROOM WISDOM, INC.
Maitake Products, Inc.

Representatives

Stephen M. O'Neill STEPHEN M. O'NEILL ESQ. PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

dietarynutritional and food supplements made from mushrooms or mushroom extracts

Publications

History of USPTO decisions and trademark events.

42 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/07/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/07/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/07/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/07/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

11/19/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/09/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/03/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/03/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/02/2015

E815

TEAS SECTION 8 & 15 RECEIVED

05/19/2015

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/10/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/11/2010

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/09/2009

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/09/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/06/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/05/2009

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/22/2009

DPCC

DIVISIONAL PROCESSING COMPLETE

03/18/2009

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/18/2009

FAXX

FAX RECEIVED

02/13/2009

IUAF

USE AMENDMENT FILED

02/11/2009

DRRR

DIVISIONAL REQUEST RECEIVED

02/11/2009

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

02/11/2009

EISU

TEAS STATEMENT OF USE RECEIVED

02/11/2009

FAXX

FAX RECEIVED

02/11/2009

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

08/12/2008

PUBO

PUBLISHED FOR OPPOSITION

05/20/2008

NPUB

NOTICE OF PUBLICATION

04/30/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/14/2008

ALIE

ASSIGNED TO LIE

04/14/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/04/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/22/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/21/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/21/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/21/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/22/2007

GNRT

NON-FINAL ACTION E-MAILED

09/22/2007

CNRT

NON-FINAL ACTION WRITTEN

09/22/2007

DOCK

ASSIGNED TO EXAMINER

09/21/2007

NWAP

NEW APPLICATION ENTERED

06/22/2007

Continuous trademark protection

Get notified about every new filing that threatens AMYLOBAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.